---
title: Etrinabdione (VCE-004.8), a B55Î± activator, promotes angiogenesis and arteriogenesis
  in critical limb ischemia
date: '2024-11-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39506809/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241108190013&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The findings presented in this study indicate that Etrinabdione
  holds promise in mitigating endothelial cell damage and senescence, while concurrently
  fostering arteriogenesis and angiogenesis. These observations position Etrinabdione
  as a compelling candidate for the treatment of PAD, and potentially other cardiovascular
  ...'
disable_comments: true
---
CONCLUSIONS: The findings presented in this study indicate that Etrinabdione holds promise in mitigating endothelial cell damage and senescence, while concurrently fostering arteriogenesis and angiogenesis. These observations position Etrinabdione as a compelling candidate for the treatment of PAD, and potentially other cardiovascular ...